MedPath

A Study to Evaluate fMRI of Active DBS Stimulation in Epilepsy

Not Applicable
Withdrawn
Conditions
Refractory Epilepsy
Interventions
Diagnostic Test: Functional magnetic resonance imaging (fMRI)
Registration Number
NCT04753983
Lead Sponsor
Mayo Clinic
Brief Summary

The purpose of this study is to use functional imaging to study the mechanisms of the anterior nucleus of the thalamus (ANT) deep brain stimulation (DBS).

Detailed Description

Researchers are testing how changing the settings on deep brain stimulation device (DBS) can help reduce the number and severity of seizures. Functional imaging will be used to study the mechanisms of ANT DBS to optimize the device settings to improve the degree of seizure reduction.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Patients who have previously undergone anterior thalamic nucleus deep brain stimulation (DBS) for refractory epilepsy.
Read More
Exclusion Criteria
  • Contraindication to MRI; prior brain resective surgery or large area of brain tissue loss (e.g., large area infarction).
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Anterior Nucleus of the Thalamus (ANT) Deep Brain Stimulation (DBS)Functional magnetic resonance imaging (fMRI)Subjects that have undergone DBS placement for treatment of refractory epilepsy will undergo a fMRI scan. During the fMRI, the subject will undergo alternating short periods of their DBS in the "on" and "off" state with high- and low frequency settings to measure the brain activation changes induced by the DBS.
Primary Outcome Measures
NameTimeMethod
Document brain activation networks with ANT stimulationResults would be available immediately following processing of the imaging data after each scan

Use resting state fMRI to map brain network activation with high and low frequency of ANT stimulation.

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath